SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-17-001163
Filing Date
2017-03-03
Accepted
2017-03-03 17:06:40
Documents
6
Period of Report
2017-04-14
Effectiveness Date
2017-03-03

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ohrp-def14a_041417.htm DEF 14A 555937
2 GRAPHIC proxystatement001.jpg GRAPHIC 6402
3 GRAPHIC finalproxy001.jpg GRAPHIC 3136
4 GRAPHIC finalproxy002.jpg GRAPHIC 651
5 GRAPHIC finalproxy003.jpg GRAPHIC 635
6 GRAPHIC finalproxy004.jpg GRAPHIC 630
  Complete submission text file 0001387131-17-001163.txt   573619
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35963 | Film No.: 17665038
SIC: 2834 Pharmaceutical Preparations